Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener

Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2018-07-18
XONIntrexon CorpSabzevari HelenPres, Precigen, Inc.S - Sale+OE$14.54-8,40216,598-34%-$122,165
D
2018-07-17
CRLCharles River Laboratories International IncMolho DavidePres, COOS - Sale+OE$120.00-11,12674,427-13%-$1,335,120
D
2018-07-16
LUNALuna Innovations IncCarilion Clinic10%S - Sale+OE$3.40-39,4972,164,330-2%-$134,290
2018-07-17
CRLCharles River Laboratories International IncGirshick BirgitCorporate EVPS - Sale$119.90-3,97818,999-17%-$476,962
D
2018-07-16
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$21.13-90,000318,705-22%-$1,901,700
AM
2018-07-06
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-6,9945,716,0100%-$265,772
M
2018-07-06
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-6,9945,716,0100%-$265,772
2018-07-09
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.40-8,9552,044,7300%-$30,447
D
2018-07-09
INCYIncyte CorpSwain Paula JEVP, HRS - Sale+OE$71.11-10,00032,963-23%-$711,100
2018-07-09
INCYIncyte CorpIyengar Vijay KEVP GPS, BD, LicensingS - Sale$71.34-6068,103-7%-$43,232
M
2018-07-06
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-6,9945,716,0100%-$265,772
2018-07-03
XONIntrexon CorpKirk Randal JCEO, 10%P - Purchase$13.37+7,479,43166,789,237+13%+$99,999,992
M
2018-07-03
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-7,7195,723,0040%-$293,347
2018-07-02
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$111.55-2,775322,178-1%-$309,540
2018-07-02
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$111.34-5,348274,451-2%-$595,462
2018-07-02
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$111.11-5,471279,799-2%-$607,865
2018-07-02
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$110.80-5,005285,270-2%-$554,552
2018-07-02
CRLCharles River Laboratories International IncFoster James CCOB, CEOS - Sale$110.53-6,401290,275-2%-$707,472
D
2018-07-02
EXELExelixis, Inc.Schwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$21.20-22,500292,793-7%-$477,000
D
2018-07-02
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale+OE$59.10-2,13577,048-3%-$126,176
D
2018-06-25
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$19.62-90,000318,705-22%-$1,765,800
M
2018-06-25
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.01-15,3585,730,7230%-$583,762
2018-06-25
CRLCharles River Laboratories International IncMassaro GeorgeDirS - Sale$115.55-30013,837-2%-$34,665
D
2018-06-25
CRLCharles River Laboratories International IncMassaro GeorgeDirS - Sale+OE$114.05-3,23014,137-19%-$368,381
M
2018-06-21
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.04-5,4415,746,0810%-$207,002
D
2018-06-15
IQVIqvia Holdings Inc.Bousbib AriSee RemarksS - Sale+OE$103.20-92,1601,331,519-6%-$9,510,912
2018-06-15
IQVIqvia Holdings Inc.Cpp Investment Board Private Holdings, Inc.10%S - Sale$103.00-9,291,0367,453,388-55%-$956,976,708
2018-06-15
IQVIqvia Holdings Inc.Tpg Group Holdings (Sbs) Advisors, Inc.DirS - Sale$103.00-6,716,25316,149,276-29%-$691,774,059
2018-06-15
IQVIqvia Holdings Inc.Connaughton JohnDirS - Sale$103.00-1,441,2363,815,315-27%-$148,447,308
2018-06-14
MEDPMedpace Holdings, Inc.Medpace Limited Partnership10%S - Sale$41.80-3,000,00010,399,997-22%-$125,400,000
2018-05-31
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.40-1002,053,6850%-$340
2018-05-31
EXELExelixis, Inc.Hessekiel JeffreyEVP, GCS - Sale$20.71-65,000255,067-20%-$1,346,150
D
2018-05-30
EXELExelixis, Inc.Feldbaum Carl BDirS - Sale+OE$20.60-34,26215,221-69%-$705,797
D
2018-06-01
EXELExelixis, Inc.Schwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$20.80-22,500292,793-7%-$468,000
M
2018-05-25
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.41-6,7002,053,7850%-$22,841
D
2018-05-23
NRCINational Research CorpNunnelly John NDirS - Sale+OE$33.88-5,06626,894-16%-$171,618
D
2018-05-22
EXELExelixis, Inc.Willsey LanceDirS - Sale+OE$21.40-50,000418,273-11%-$1,070,000
D
2018-05-24
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$20.55-90,000318,705-22%-$1,849,500
DM
2018-05-21
NRCINational Research CorpNunnelly John NDirS - Sale+OE$34.50-13,40131,894-30%-$462,295
2018-05-21
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.40-9152,060,4850%-$3,111
2018-05-22
ELOXEloxx Pharmaceuticals, Inc.Ward RobertCEOP - Purchase$14.34+5,00015,000+50%+$71,700
DM
2018-05-18
NRCINational Research CorpBerwick Donald MDirS - Sale+OE$34.54-25,3090-100%-$874,231
M
2018-05-17
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.40-102,9302,061,400-5%-$349,962
DM
2018-05-17
NRCINational Research CorpNunnelly John NDirS - Sale+OE$34.66-31,77831,894-50%-$1,101,487
2018-05-18
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale$21.61-3,663160,967-2%-$79,157
D
2018-05-16
NRCINational Research CorpNunnelly John NDirS - Sale+OE$34.67-5,95241,139-13%-$206,384
DM
2018-05-14
NRCINational Research CorpNunnelly John NDirS - Sale+OE$34.47-22,98541,894-35%-$792,364
2018-05-15
PIRSPieris Pharmaceuticals, Inc.Geraghty James ADirP - Purchase$5.75+10,00020,000+100%+$57,500
2018-05-14
CRLCharles River Laboratories International IncMassaro GeorgeDirS - Sale$107.19-1,21813,837-8%-$130,558
2018-05-10
IQVIqvia Holdings Inc.Evanisko Michael JDirS - Sale$100.00-8157,358-10%-$81,500
DM
2018-05-10
NRCINational Research CorpNunnelly John NDirS - Sale+OE$33.90-18,51441,894-31%-$627,538
D
2018-05-11
EXELExelixis, Inc.Marchesi Vincent TDirS - Sale+OE$19.03-15,000125,913-11%-$285,450
2018-05-10
EXASExact Sciences CorpWyzga Michael SDirS - Sale$51.53-7,40210,974-40%-$381,447
D
2018-05-09
EXELExelixis, Inc.Cohen CharlesDirS - Sale+OE$21.42-15,000248,180-6%-$321,300
M
2018-05-08
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.43-64,6082,075,444-3%-$221,341
D
2018-05-09
NRCINational Research CorpNunnelly John NDirS - Sale+OE$33.31-8,65451,894-14%-$288,239
DM
2018-05-07
NRCINational Research CorpNunnelly John NDirS - Sale+OE$34.13-8,59451,894-14%-$293,300
2018-05-07
MEDPMedpace Holdings, Inc.Medpace Limited Partnership10%S - Sale$35.49-3,000,00013,399,997-18%-$106,470,000
D
2018-05-07
EXELExelixis, Inc.Papadopoulos SteliosDirS - Sale+OE$22.15-15,0001,034,314-1%-$332,250
2018-05-04
EXELExelixis, Inc.Hessekiel JeffreyEVP, GCS - Sale$22.36-20,000320,067-6%-$447,200
DM
2018-05-04
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale+OE$22.17-27,549164,630-14%-$610,847
D
2018-05-03
NRCINational Research CorpNunnelly John NDirS - Sale+OE$34.49-18,05651,894-26%-$622,833
2018-05-03
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.40-3,9002,140,0520%-$13,260
D
2018-05-03
EXELExelixis, Inc.Schwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.09-22,500292,793-7%-$519,417
2018-05-02
INCYIncyte CorpHoppenot HerveCOB , CEOP - Purchase$60.94+15,000276,690+6%+$914,100
M
2018-05-01
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.41-20,3782,143,952-1%-$69,489
D
2018-05-01
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale+OE$104.23-94512,778-7%-$98,499
2018-04-30
PIRSPieris Pharmaceuticals, Inc.Orbimed Advisors LLCSee Remarks, 10%S - Sale$6.35-1,000,00038,870-96%-$6,350,000
D
2018-04-30
INCYIncyte CorpSwain Paula JEVP, HRS - Sale+OE$62.43-80,00033,367-71%-$4,994,400
2018-04-30
ELOXEloxx Pharmaceuticals, Inc.Shabtai Gilad10%P - Purchase$9.75+75,0003,351,770+2%+$731,250
2018-04-30
ELOXEloxx Pharmaceuticals, Inc.Pontifax Management 4 G.P. (2015) Ltd.10%P - Purchase$9.75+350,000520,396+205%+$3,412,500
2018-04-30
ELOXEloxx Pharmaceuticals, Inc.Nussbaum RanDirP - Purchase$9.75+350,0007,708,582+5%+$3,412,500
2018-04-30
ELOXEloxx Pharmaceuticals, Inc.Kleijwegt MartijnDirP - Purchase$9.75+300,0002,953,673+11%+$2,925,000
2018-04-30
ELOXEloxx Pharmaceuticals, Inc.Kariv TomerDirP - Purchase$9.75+350,0007,708,582+5%+$3,412,500
D
2018-04-23
NRCINational Research CorpHays Michael D.CEOS - Sale+OE$35.00-80141,1660%-$2,800
2018-04-18
IQVIqvia Holdings Inc.Evanisko Michael JDirS - Sale$100.00-8156,101-12%-$81,500
D
2018-04-16
EXELExelixis, Inc.Wyszomierski Jack LDirS - Sale+OE$20.25-14,95993,844-14%-$302,920
D
2018-04-16
EXELExelixis, Inc.Garber Alan MDirS - Sale+OE$20.25-15,00061,329-20%-$303,750
M
2018-04-16
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.41-39,1722,046,313-2%-$133,522
DM
2018-04-12
LUNALuna Innovations IncCarilion Clinic10%S - Sale+OE$3.39-78,0452,085,485-4%-$264,262
D
2018-04-11
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$20.78-90,000318,604-22%-$1,870,200
2018-04-12
EXASExact Sciences CorpZanotti Katherine SDirS - Sale$45.00-7,232105,814-6%-$325,440
M
2018-04-10
LUNALuna Innovations IncCarilion Clinic10%S - Sale$3.43-44,0122,120,318-2%-$151,014
2018-04-10
EXASExact Sciences CorpDoyle James EdwardDirS - Sale$40.97-3,09835,181-8%-$126,925
2018-04-10
EXASExact Sciences CorpCarey Thomas D.DirS - Sale$39.73-8,44852,410-14%-$335,630
M
2018-04-03
ELOXEloxx Pharmaceuticals, Inc.Shabtai Gilad10%P - Purchase$9.46+8,3003,276,7700%+$78,545
D
2018-04-02
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$28.75-3,00032,600-8%-$86,250
D
2018-04-02
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale+OE$40.12-2,12270,690-3%-$85,124
2018-03-29
ELOXEloxx Pharmaceuticals, Inc.Shabtai Gilad10%P - Purchase$9.64+4,5003,268,4700%+$43,380
D
2018-03-29
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$29.50-10032,6000%-$2,950
D
2018-03-28
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$28.87-4,06832,600-11%-$117,441
2018-03-26
ELOXEloxx Pharmaceuticals, Inc.Avnur ZafriraDirP - Purchase$9.49+2,0002,263+760%+$18,980
DM
2018-03-26
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$28.66-4,99132,600-13%-$143,043
DM
2018-03-22
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$30.15-35632,600-1%-$10,732
2018-03-23
ELOXEloxx Pharmaceuticals, Inc.Ward RobertCEOP - Purchase$8.99+10,00010,000New+$89,900
2018-03-23
ELOXEloxx Pharmaceuticals, Inc.Weaver Gregory LCFOP - Purchase$8.56+4,5004,500New+$38,520
M
2018-03-21
ELOXEloxx Pharmaceuticals, Inc.Nussbaum RanDirP - Purchase$7.76+12,6007,615,2490%+$97,830
M
2018-03-21
ELOXEloxx Pharmaceuticals, Inc.Kariv TomerDirP - Purchase$7.76+12,6007,615,2490%+$97,830
M
2018-03-21
ELOXEloxx Pharmaceuticals, Inc.Pontifax Management 4 G.P. (2015) Ltd.10%P - Purchase$7.76+12,600427,063+3%+$97,830
2018-03-21
ELOXEloxx Pharmaceuticals, Inc.Avnur ZafriraDirP - Purchase$7.60+263263New+$1,999

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top